We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Correlogic Systems and JEOL Sign Research and Development Agreement
News

Correlogic Systems and JEOL Sign Research and Development Agreement

Correlogic Systems and JEOL Sign Research and Development Agreement
News

Correlogic Systems and JEOL Sign Research and Development Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Correlogic Systems and JEOL Sign Research and Development Agreement"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Correlogic Systems, Inc. and JEOL, Ltd. announced the signing of a research and development agreement focused on further enhancing the performance of mass spectrometry in a clinical setting.

JEOL, headquartered in Tokyo, is a global manufacturer of scientific instruments used for research and development in the fields of nanotechnology, life sciences, optical communication, forensics, and biotechnology. Correlogic, based in Rockville, Maryland has pioneered the use of pattern recognition technologies for the development of proteomic, metabolomic, and genomic based clinical prognostic and clinical diagnostic tests.

Correlogic and JEOL have collaborated for more than a year under an informal agreement, and have made great strides in the continuing validation of various mass spectrometer-based assays. Details of the agreement were not released.

Over the past year, we have had a very close and productive research collaboration with JEOL," said Peter J. Levine, President and CEO of Correlogic Systems, Inc. "This agreement formalizes our link to one of the world's leading mass spectrometer and NMR manufacturers.

Advertisement